Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pa...

Full description

Saved in:
Bibliographic Details
Published in:Allergy, asthma & immunology research Vol. 8; no. 6; pp. 527 - 534
Main Authors: Yoo, Kwang Ha, Ahn, Hae Ryun, Park, Jae Kyoung, Kim, Jong Woong, Nam, Gui Hyun, Hong, Soon Kwan, Kim, Mee Ja, Ghoshal, Aloke Gopal, Muttalif, Abdul Razak Bin Abdul, Lin, Horng Chyuan, Thanaviratananich, Sanguansak, Bagga, Shalini, Faruqi, Rab, Sajjan, Shiva, Baidya, Santwona, Wang, De Yun, Cho, Sang Heon
Format: Journal Article
Language:English
Published: Korea (South) The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 01-11-2016
대한천식알레르기학회
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea. Consecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity. The study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs. Respiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.
AbstractList PURPOSEThe Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea.METHODSConsecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity.RESULTSThe study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs.CONCLUSIONSRespiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.
Purpose: The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea. Methods: Consecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity. Results: The study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs. Conclusions: Respiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease. KCI Citation Count: 35
The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea. Consecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity. The study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs. Respiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.
Purpose The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea. Methods Consecutive participants aged > or =18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity. Results The study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs. Conclusions Respiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.
Author Faruqi, Rab
Park, Jae Kyoung
Lin, Horng Chyuan
Wang, De Yun
Baidya, Santwona
Kim, Mee Ja
Hong, Soon Kwan
Ghoshal, Aloke Gopal
Yoo, Kwang Ha
Muttalif, Abdul Razak Bin Abdul
Sajjan, Shiva
Cho, Sang Heon
Ahn, Hae Ryun
Kim, Jong Woong
Nam, Gui Hyun
Bagga, Shalini
Thanaviratananich, Sanguansak
AuthorAffiliation 6 Coco ENT Clinic, Seoul, Korea
9 Institute of Respiratory Medicine, Kuala Lumpur, Malaysia
1 Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
7 Myung ENT Clinic, Seoul, Korea
16 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
2 Dami IM Clinic, Seoul, Korea
8 National Allergy Asthma Bronchitis Institute, Kolkata, India
13 Merck & Co., Inc. (retired), Kenilworth, NJ, USA
10 Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
4 Jong-Woong Kim IM Clinic, Seoul, Korea
3 Seoulbom IM Clinic, Seoul, Korea
5 Hamchun Medical Clinic, Incheon, Korea
12 Merck & Co., Inc., Kenilworth, NJ, USA
14 Optum, Sydney, Australia
15 Department of Otolaryngology, National University of Singapore, Singapore, Singapore
11 Department of Otorhinolaryngology, Khon Kaen University, Khon Kaen, Thailand
AuthorAffiliation_xml – name: 8 National Allergy Asthma Bronchitis Institute, Kolkata, India
– name: 16 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
– name: 15 Department of Otolaryngology, National University of Singapore, Singapore, Singapore
– name: 12 Merck & Co., Inc., Kenilworth, NJ, USA
– name: 6 Coco ENT Clinic, Seoul, Korea
– name: 11 Department of Otorhinolaryngology, Khon Kaen University, Khon Kaen, Thailand
– name: 9 Institute of Respiratory Medicine, Kuala Lumpur, Malaysia
– name: 2 Dami IM Clinic, Seoul, Korea
– name: 3 Seoulbom IM Clinic, Seoul, Korea
– name: 10 Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
– name: 7 Myung ENT Clinic, Seoul, Korea
– name: 13 Merck & Co., Inc. (retired), Kenilworth, NJ, USA
– name: 4 Jong-Woong Kim IM Clinic, Seoul, Korea
– name: 5 Hamchun Medical Clinic, Incheon, Korea
– name: 14 Optum, Sydney, Australia
– name: 1 Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Kwang Ha
  surname: Yoo
  fullname: Yoo, Kwang Ha
  organization: Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
– sequence: 2
  givenname: Hae Ryun
  surname: Ahn
  fullname: Ahn, Hae Ryun
  organization: Dami IM Clinic, Seoul, Korea
– sequence: 3
  givenname: Jae Kyoung
  surname: Park
  fullname: Park, Jae Kyoung
  organization: Seoulbom IM Clinic, Seoul, Korea
– sequence: 4
  givenname: Jong Woong
  surname: Kim
  fullname: Kim, Jong Woong
  organization: Jong-Woong Kim IM Clinic, Seoul, Korea
– sequence: 5
  givenname: Gui Hyun
  surname: Nam
  fullname: Nam, Gui Hyun
  organization: Hamchun Medical Clinic, Incheon, Korea
– sequence: 6
  givenname: Soon Kwan
  surname: Hong
  fullname: Hong, Soon Kwan
  organization: Coco ENT Clinic, Seoul, Korea
– sequence: 7
  givenname: Mee Ja
  surname: Kim
  fullname: Kim, Mee Ja
  organization: Myung ENT Clinic, Seoul, Korea
– sequence: 8
  givenname: Aloke Gopal
  surname: Ghoshal
  fullname: Ghoshal, Aloke Gopal
  organization: National Allergy Asthma Bronchitis Institute, Kolkata, India
– sequence: 9
  givenname: Abdul Razak Bin Abdul
  surname: Muttalif
  fullname: Muttalif, Abdul Razak Bin Abdul
  organization: Institute of Respiratory Medicine, Kuala Lumpur, Malaysia
– sequence: 10
  givenname: Horng Chyuan
  surname: Lin
  fullname: Lin, Horng Chyuan
  organization: Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
– sequence: 11
  givenname: Sanguansak
  surname: Thanaviratananich
  fullname: Thanaviratananich, Sanguansak
  organization: Department of Otorhinolaryngology, Khon Kaen University, Khon Kaen, Thailand
– sequence: 12
  givenname: Shalini
  surname: Bagga
  fullname: Bagga, Shalini
  organization: Merck & Co., Inc., Kenilworth, NJ, USA
– sequence: 13
  givenname: Rab
  surname: Faruqi
  fullname: Faruqi, Rab
  organization: Merck & Co., Inc. (retired), Kenilworth, NJ, USA
– sequence: 14
  givenname: Shiva
  surname: Sajjan
  fullname: Sajjan, Shiva
  organization: Merck & Co., Inc. (retired), Kenilworth, NJ, USA
– sequence: 15
  givenname: Santwona
  surname: Baidya
  fullname: Baidya, Santwona
  organization: Optum, Sydney, Australia
– sequence: 16
  givenname: De Yun
  surname: Wang
  fullname: Wang, De Yun
  organization: Department of Otolaryngology, National University of Singapore, Singapore, Singapore
– sequence: 17
  givenname: Sang Heon
  surname: Cho
  fullname: Cho, Sang Heon
  email: shcho@snu.ac.kr
  organization: Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. shcho@snu.ac.kr
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27582404$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002162292$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqNkl1v0zAUhi20iY2xH8AN8iWT2uCP2Em4QMq6DyYmFZVxbZ06zmqW2sVOJvXf47Sjgjvsi2PpPOeVX_t9g46cdwahd5RkOZXlRwAbMkaozMpMZoIVr9ApIxWbFlzyo8NZiBN0HuNPkhaneS7z1-iEFaJkOclP0XA5hMY47Fu8MHFjA_Q-bPGVjQaiwdbhrz4Y-IRrh-fLaMIz9NY76PD3fmi22Dtcd50Jj1bjxco629s4wXXsV2uY4Nn829UEg2t2PR-tG-JIvEXHLXTRnL_UM_Tj5vph9mV6P7-9m9X3Uy0466cAba5bLSlUJM8JkUKQRnKqTZHcLYGVOm0jWAK5NIJUQCoDAJKWUErBz9DFXteFVj1pqzzYXX306imoevFwp2h6DFaSxH7es5thuTaNNq4P0KlNsGsI293kvx1nV0nnWQlCKRE8CXx4EQj-12Bir9Y2atN14IwfoqIlLzgv2H-hVEpeVWK0QPeoDj7GYNrDjShRYxDUGAQ1BkGVSqoUhDTz_m8rh4k_385_A3WLsRc
CitedBy_id crossref_primary_10_1002_alr_23090
crossref_primary_10_4168_aair_2017_9_3_220
crossref_primary_10_4168_aair_2019_11_1_43
crossref_primary_10_4168_aair_2017_9_3_265
crossref_primary_10_1038_s41598_021_81022_z
crossref_primary_10_1111_eci_13396
crossref_primary_10_5124_jkma_2017_60_1_81
crossref_primary_10_3904_kjim_2019_198
crossref_primary_10_1007_s40521_021_00282_2
crossref_primary_10_1111_cea_13295
crossref_primary_10_1177_17534666241236025
crossref_primary_10_1186_s13223_023_00816_0
crossref_primary_10_4168_aair_2017_9_5_394
crossref_primary_10_1097_MD_0000000000011705
crossref_primary_10_3390_children10091571
crossref_primary_10_1016_j_vhri_2019_02_002
crossref_primary_10_1016_j_ceh_2021_08_001
crossref_primary_10_4168_aair_2018_10_3_236
crossref_primary_10_1017_S0022215122001219
crossref_primary_10_17116_rosrino201927041215
crossref_primary_10_1159_000489015
crossref_primary_10_3390_diagnostics13243637
crossref_primary_10_1007_s11869_021_00997_w
crossref_primary_10_4168_aard_2017_5_4_205
crossref_primary_10_4168_aard_2020_8_2_53
crossref_primary_10_17116_otorino201984061118
crossref_primary_10_1111_resp_13559
crossref_primary_10_1111_resp_13147
crossref_primary_10_4168_aair_2019_11_3_394
crossref_primary_10_1016_j_jaip_2017_09_002
crossref_primary_10_4168_aair_2018_10_4_370
crossref_primary_10_1002_lio2_232
crossref_primary_10_3390_life14050553
crossref_primary_10_1016_j_jaci_2017_03_050
crossref_primary_10_4168_aair_2018_10_5_533
crossref_primary_10_1016_j_pedneo_2020_03_018
crossref_primary_10_4046_trd_2023_0100
crossref_primary_10_1007_s00520_022_07197_x
crossref_primary_10_1016_j_jaci_2017_09_009
crossref_primary_10_4178_epih_e2022010
crossref_primary_10_1038_s12276_020_0376_2
crossref_primary_10_2486_indhealth_2022_0174
crossref_primary_10_5124_jkma_2018_61_9_533
crossref_primary_10_21053_ceo_2017_00143
crossref_primary_10_1080_19390211_2019_1694121
crossref_primary_10_4168_aair_2018_10_3_216
crossref_primary_10_4168_aair_2019_11_6_795
crossref_primary_10_3390_diagnostics14111153
crossref_primary_10_4168_aair_2018_10_6_628
crossref_primary_10_1097_MD_0000000000013227
crossref_primary_10_4046_trd_2018_0035
crossref_primary_10_1038_s41598_018_33316_y
crossref_primary_10_1038_s41598_023_32485_9
crossref_primary_10_1097_JOM_0000000000002962
crossref_primary_10_1177_14799731241233301
crossref_primary_10_3346_jkms_2023_38_e108
crossref_primary_10_23736_S2724_6302_22_02454_9
crossref_primary_10_1007_s00484_019_01804_z
crossref_primary_10_1038_s41598_019_39379_9
crossref_primary_10_4168_aair_2023_15_1_19
crossref_primary_10_1155_2022_3485757
crossref_primary_10_1093_occmed_kqy012
crossref_primary_10_4168_aard_2023_11_3_117
Cites_doi 10.2500/aap.2011.32.3479
10.1111/j.1365-2222.2005.02251.x
10.1034/j.1398-9995.1999.00813.x
10.5588/ijtld.13.0634
10.1186/1471-2466-9-24
10.2165/00019053-199304050-00006
10.5415/apallergy.2014.4.4.222
10.1111/j.1440-1843.2011.01951.x
10.2500/aap.2016.37.3925
10.2500/ajra.2011.25.3630
10.1183/09059180.00002110
10.2500/ajra.2010.24.3513
10.1016/S0954-6111(03)80020-3
10.5415/apallergy.2014.4.2.75
10.4168/aair.2011.3.1.34
10.1111/j.1398-9995.2007.01620.x
10.2165/00044011-199611050-00004
10.1016/j.vhri.2015.11.004
10.1186/1471-2458-11-612
10.2500/ajra.2014.28.4040
ContentType Journal Article
Copyright Copyright © 2016 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2016
Copyright_xml – notice: Copyright © 2016 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2016
DBID NPM
AAYXX
CITATION
7X8
7T5
7U7
C1K
H94
5PM
ACYCR
DOI 10.4168/aair.2016.8.6.527
DatabaseName PubMed
CrossRef
MEDLINE - Academic
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic

PubMed
AIDS and Cancer Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-7363
EndPage 534
ExternalDocumentID oai_kci_go_kr_ARTI_1275280
10_4168_aair_2016_8_6_527
27582404
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAKDD
ACPRK
ADBBV
ADRAZ
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
C~G
DIK
DYU
E3Z
EF.
F5P
GX1
HYE
KQ8
M48
M~E
NPM
O5R
O5S
OK1
PGMZT
RPM
AAYXX
CITATION
7X8
7T5
7U7
C1K
H94
5PM
ACYCR
OZF
ID FETCH-LOGICAL-c532t-aaf4cfc61a9044006550d631ce7209ba28c8c8e52aaf36e509a09eaaa618a8653
IEDL.DBID RPM
ISSN 2092-7355
IngestDate Tue Nov 21 21:17:33 EST 2023
Tue Sep 17 21:08:20 EDT 2024
Sat Aug 17 04:12:03 EDT 2024
Sat Oct 26 05:09:54 EDT 2024
Fri Aug 23 01:09:25 EDT 2024
Sat Nov 02 12:31:21 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Respiratory tract disease
cost of illness
health care costs
Korea
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-aaf4cfc61a9044006550d631ce7209ba28c8c8e52aaf36e509a09eaaa618a8653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-SER000002443.2016.8.6.002
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011053/
PMID 27582404
PQID 1816639955
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1275280
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5011053
proquest_miscellaneous_1837337253
proquest_miscellaneous_1816639955
crossref_primary_10_4168_aair_2016_8_6_527
pubmed_primary_27582404
PublicationCentury 2000
PublicationDate 2016-11-01
PublicationDateYYYYMMDD 2016-11-01
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Allergy, asthma & immunology research
PublicationTitleAlternate Allergy Asthma Immunol Res
PublicationYear 2016
Publisher The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Publisher_xml – name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
– name: 대한천식알레르기학회
References Kim (10.4168/aair.2016.8.6.527_ref8) 2010; 24
Global Initiative for Chronic Obstructive Lung Disease (10.4168/aair.2016.8.6.527_ref16) 2010
Kim (10.4168/aair.2016.8.6.527_ref6) 2011; 25
Global Initiatives for Asthma (10.4168/aair.2016.8.6.527_ref15) 2011
World Health Organization (10.4168/aair.2016.8.6.527_ref14) 2010
Wouters (10.4168/aair.2016.8.6.527_ref27) 2003; 97
Bahadori (10.4168/aair.2016.8.6.527_ref28) 2009; 9
Wang (10.4168/aair.2016.8.6.527_ref12) 2016; 9
Song (10.4168/aair.2016.8.6.527_ref3) 2014; 4
Kim (10.4168/aair.2016.8.6.527_ref22) 2014; 4
Fletcher (10.4168/aair.2016.8.6.527_ref24) 2011; 11
Bousquet (10.4168/aair.2016.8.6.527_ref18) 2008; 63
10.4168/aair.2016.8.6.527_ref26
Reilly (10.4168/aair.2016.8.6.527_ref19) 1993; 4
Demoly (10.4168/aair.2016.8.6.527_ref25) 2010; 19
Kim (10.4168/aair.2016.8.6.527_ref9) 2013; 8
Kim (10.4168/aair.2016.8.6.527_ref11) 2014; 18
Fokkens (10.4168/aair.2016.8.6.527_ref17) 2007
Kim (10.4168/aair.2016.8.6.527_ref10) 2011; 3
Berrettini (10.4168/aair.2016.8.6.527_ref21) 1999; 54
Reilly (10.4168/aair.2016.8.6.527_ref23) 1996; 11
Yoo (10.4168/aair.2016.8.6.527_ref2) 2011; 16
Bousquet (10.4168/aair.2016.8.6.527_ref20) 2005; 35
Rhee (10.4168/aair.2016.8.6.527_ref4) 2014; 28
Park (10.4168/aair.2016.8.6.527_ref5) 2009; 27
Cho (10.4168/aair.2016.8.6.527_ref13) 2016; 37
Lee (10.4168/aair.2016.8.6.527_ref7) 2011; 32
World Health Organization (10.4168/aair.2016.8.6.527_ref1) 2007
References_xml – volume: 32
  start-page: 35
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref7
  publication-title: Allergy Asthma Proc
  doi: 10.2500/aap.2011.32.3479
  contributor:
    fullname: Lee
– volume: 35
  start-page: 723
  year: 2005
  ident: 10.4168/aair.2016.8.6.527_ref20
  publication-title: Clin Exp Allergy
  doi: 10.1111/j.1365-2222.2005.02251.x
  contributor:
    fullname: Bousquet
– volume: 54
  start-page: 242
  year: 1999
  ident: 10.4168/aair.2016.8.6.527_ref21
  publication-title: Allergy
  doi: 10.1034/j.1398-9995.1999.00813.x
  contributor:
    fullname: Berrettini
– volume: 18
  start-page: 737
  year: 2014
  ident: 10.4168/aair.2016.8.6.527_ref11
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.13.0634
  contributor:
    fullname: Kim
– volume-title: Global strategy for asthma management and prevention (2011 update)
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref15
  contributor:
    fullname: Global Initiatives for Asthma
– volume: 9
  start-page: 24
  year: 2009
  ident: 10.4168/aair.2016.8.6.527_ref28
  publication-title: BMC Pulm Med
  doi: 10.1186/1471-2466-9-24
  contributor:
    fullname: Bahadori
– volume-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
  year: 2010
  ident: 10.4168/aair.2016.8.6.527_ref16
  contributor:
    fullname: Global Initiative for Chronic Obstructive Lung Disease
– volume-title: Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach
  year: 2007
  ident: 10.4168/aair.2016.8.6.527_ref1
  contributor:
    fullname: World Health Organization
– volume: 4
  start-page: 353
  year: 1993
  ident: 10.4168/aair.2016.8.6.527_ref19
  publication-title: Pharmacoeconomics
  doi: 10.2165/00019053-199304050-00006
  contributor:
    fullname: Reilly
– start-page: 1
  year: 2007
  ident: 10.4168/aair.2016.8.6.527_ref17
  publication-title: Rhinol Suppl
  contributor:
    fullname: Fokkens
– volume: 4
  start-page: 222
  year: 2014
  ident: 10.4168/aair.2016.8.6.527_ref22
  publication-title: Asia Pac Allergy
  doi: 10.5415/apallergy.2014.4.4.222
  contributor:
    fullname: Kim
– volume: 27
  start-page: 167
  year: 2009
  ident: 10.4168/aair.2016.8.6.527_ref5
  publication-title: Asian Pac J Allergy Immunol
  contributor:
    fullname: Park
– volume: 16
  start-page: 659
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref2
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.01951.x
  contributor:
    fullname: Yoo
– volume: 37
  start-page: 131
  year: 2016
  ident: 10.4168/aair.2016.8.6.527_ref13
  publication-title: Allergy Asthma Proc
  doi: 10.2500/aap.2016.37.3925
  contributor:
    fullname: Cho
– volume: 25
  start-page: 117
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref6
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2011.25.3630
  contributor:
    fullname: Kim
– volume: 8
  start-page: 561
  year: 2013
  ident: 10.4168/aair.2016.8.6.527_ref9
  publication-title: Int J Chron Obstruct Pulmon Dis
  contributor:
    fullname: Kim
– volume-title: International statistical classification of diseases and related health problems
  year: 2010
  ident: 10.4168/aair.2016.8.6.527_ref14
  contributor:
    fullname: World Health Organization
– volume: 19
  start-page: 150
  year: 2010
  ident: 10.4168/aair.2016.8.6.527_ref25
  publication-title: Eur Respir Rev
  doi: 10.1183/09059180.00002110
  contributor:
    fullname: Demoly
– volume: 24
  start-page: e110
  year: 2010
  ident: 10.4168/aair.2016.8.6.527_ref8
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2010.24.3513
  contributor:
    fullname: Kim
– volume: 97
  start-page: S3
  issue: Suppl C
  year: 2003
  ident: 10.4168/aair.2016.8.6.527_ref27
  publication-title: Respir Med
  doi: 10.1016/S0954-6111(03)80020-3
  contributor:
    fullname: Wouters
– volume: 4
  start-page: 75
  year: 2014
  ident: 10.4168/aair.2016.8.6.527_ref3
  publication-title: Asia Pac Allergy
  doi: 10.5415/apallergy.2014.4.2.75
  contributor:
    fullname: Song
– volume: 3
  start-page: 34
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref10
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2011.3.1.34
  contributor:
    fullname: Kim
– volume: 63
  start-page: 8
  issue: Suppl 86
  year: 2008
  ident: 10.4168/aair.2016.8.6.527_ref18
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2007.01620.x
  contributor:
    fullname: Bousquet
– volume: 11
  start-page: 278
  year: 1996
  ident: 10.4168/aair.2016.8.6.527_ref23
  publication-title: Clin Drug Investig
  doi: 10.2165/00044011-199611050-00004
  contributor:
    fullname: Reilly
– ident: 10.4168/aair.2016.8.6.527_ref26
– volume: 9
  start-page: 72
  year: 2016
  ident: 10.4168/aair.2016.8.6.527_ref12
  publication-title: Value Health Reg Issues
  doi: 10.1016/j.vhri.2015.11.004
  contributor:
    fullname: Wang
– volume: 11
  start-page: 612
  year: 2011
  ident: 10.4168/aair.2016.8.6.527_ref24
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-11-612
  contributor:
    fullname: Fletcher
– volume: 28
  start-page: e107
  year: 2014
  ident: 10.4168/aair.2016.8.6.527_ref4
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2014.28.4040
  contributor:
    fullname: Rhee
SSID ssj0000314464
Score 2.3896804
Snippet The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the...
PURPOSEThe Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the...
Purpose The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine...
Purpose: The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine...
SourceID nrf
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 527
SubjectTerms Original
내과학
Title Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis
URI https://www.ncbi.nlm.nih.gov/pubmed/27582404
https://www.proquest.com/docview/1816639955
https://search.proquest.com/docview/1837337253
https://pubmed.ncbi.nlm.nih.gov/PMC5011053
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002162292
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Allergy, 2016, Asthma & Immunology Research, 8(6), , pp.527-534
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb5swFLeWHqZdpq37Yh-VN-00BQI2Nma3KGnVqupadZu0m2UMNKiLqUI47L_fexDSppp6mDhwsEHW-z38fuZ9EfLZgolloZW-lEnqx3GZ-FlsUp-VuciZLJjteiwdf0--_VLzQyyTI4ZcmC5o32ZV4H4vA1ctutjKm6WdDHFik4uzmUCjJfhkREbADe8c0bvtl-MRB73JLEyBPYJB7b2ZQD3UxJgKq4BGMlCBDATDJnwMODMYtnjHNI3cqvwX67wfPHnHGh09I083NJJO--U-J48Kt08en20c5S9I26cn0Lqkl7fOdDrv3TG0cvS0Brr4lU4dPc-2f2bhlRhY-IfWjk4xSRD2RXq5qDDCqBnTabNeLM2Yzs4v5mNqXN6N1U3lWgz9al6Sn0eHP2bH_qbDgm8FZ2vfmDK2pZWRSbH1NNAREeaSR7ZIQHiZYcrCVQgGE7ksgFyYMC2MMTJSRknBX5E9V7viDaEl5rgiGyozGYMByIB6GhGpPClDrnLhkS-DcPVNX0hDwwEEQdEIikZQtNJSAyge-QTi19e20lj-Gu9Xtb5eaSD5Jxpr0jMVeuTjgI6GbwIdHcYVddvoCJ2hmLMrHprDE84TJrhHXveIbtc1KIRHkh2stxNwUbsjoKpdbe6Nar797yffkScoiT7d8T3ZW6_a4gMZNXl7AIz_5PSg0_a_ub4BMA
link.rule.ids 230,315,729,782,786,887,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb5swFLeWTtp22Xc39ulNO02BgI0N7BYlrVK1aauuk3azjIEFdTFVCIf993sPQtZM0w4VBw5-IOP37Pd7vC9CPhlQscw30pUyStwwLCI3DXXisiITGZM5M22PpdnX6PR7PD3AMjmiz4Vpg_ZNWnr259Kz5aKNrbxemlEfJzY6n08EKi3BRwNyF_arz28Y6e0BzNHIQX8y8xPAj6BSO38mgI94pHWJdUAD6cWe9ATDNnwMUDOotnBHOQ3sqvgX7vw7fPKGPjp8dMsveUwebgAoHXfDT8id3D4l9-YbF_sz0nSJDbQq6MUfNzyddo4cWlp6XAHQ_ELHlp6l23-68EoMSfxFK0vHmF4IJyq9WJQYm1QP6bheL5Z6SCdn59Mh1TZrx6q6tA0GjdXPybfDg8vJzN30ZnCN4Gztal2EpjAy0Ak2rQYgI_xM8sDkESx6qlls4MoFA0Iuc4Al2k9yrbUMYh1LwffJnq1s_pLQArNjEUcVqQxBdaQAWrUI4iwqfB5nwiGfe6ao664EhwLTBZmpkJkKmaliJRUw0yEfgW3qypQKC2fj_UelrlYKzIMjhdXsWew75EPPVQW7CV0k2uZVU6sA3aiY7Sv-R8MjziMmuENedJKwnVcvSA6JdmRkS4CT2h0B0Wirem9E4dWtn3xP7s8u5yfq5Oj0-DV5gKvSJU2-IXvrVZO_JYM6a961e-U3PR4VsQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELboIq248GYJT4M4oeZlx07CrWq32tWyu9UCEjfLcRIaLXWqpjnw75lJ2rJFiAMohxw8iRzP2PNN5kXIOwMqlgVGulLGqRtFZexmkU5dVuYiZ7JgpuuxdPIpvviaTI6xTM6u1VcXtG-yyrPfF56t5l1s5XJh_G2cmD87HwtUWoL7y7z0B-Q27NlA3DDUu0OYo6GDPmUWpIAhQa32Pk0AIImvdYW1QEPpJZ70BMNWfAyQM6i3aE9BDeyq_BP2_D2E8oZOmt77j6-5T-5ugCgd9SQPyK3CPiSH5xtX-yPS9gkOtC7p1S93PJ30Dh1aWXpWA-D8QEeWXma7f7vwSgxN_EFrS0eYZggnK72aVxij1AzpqFnPF3pIx5ezyZBqm3djdVPZFoPHmsfky_T48_jE3fRocI3gbO1qXUamNDLUKTavBkAjglzy0BQxLHymWWLgKgQDQi4LgCc6SAuttQwTnUjBn5ADW9viKaElZskiniozGYEKyQC8ahEmeVwGPMmFQ95vGaOWfSkOBSYMMlQhQxUyVCVKKmCoQ94C69S1qRQW0Mb7t1pdrxSYCacKq9qzJHDImy1nFewqdJVoW9Rto0J0p2LWr_gbDY85j5ngDjnqpWE3r60wOSTek5MdAU5qfwTEo6vuvRGHZ__85GtyOJtM1cfTi7Pn5A4uSp87-YIcrFdt8ZIMmrx91W2XnwKeGDE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Burden+of+Respiratory+Disease+in+Korea%3A+An+Observational+Study+on+Allergic+Rhinitis%2C+Asthma%2C+COPD%2C+and+Rhinosinusitis&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Yoo%2C+Kwang-Ha&rft.au=Ahn%2C+Hae-Ryun&rft.au=Park%2C+Jae-Kyoung&rft.au=Kim%2C+Jong-Woong&rft.date=2016-11-01&rft.issn=2092-7355&rft.eissn=2092-7363&rft.volume=8&rft.issue=6&rft.spage=527&rft.epage=534&rft_id=info:doi/10.4168%2Faair.2016.8.6.527&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon